More importantly, most patients treated with CD19 or B cell maturation antigen (BCMA ... or control of established melanoma tumors by TCR-T cells. The GEMs discovered from the phenotypic screen ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). The company’s tetraspecific antibody controlled tumors and improved survival in ...